Covid-19 Impact on the Global Cell-Based Assays Market
The COVID-19 pandemic has increased the
burden on healthcare systems across the globe. According to the WHO, there were
96,012,792 confirmed cases of COVID-19, including 2,075,870 deaths (as of
January 22, 2021). Due to the pandemic, companies have scaled up R&D
efforts to develop a vaccine and drugs against the SARS-CoV-2 virus.
Vaccine-related research activities in pharmaceutical & biotechnological
companies,...
Cell-based Assays Market worth $22.0 billion by 2025
The growing preference for cell-based assays in drug discovery, increasing funding for cell-based research, and growth in the number of drug discovery activities are the key factors supporting the growth of the market. However, the growth of the market is likely to be restrained by factors such as the high cost of instruments, restrictions on reagent use, and the lack of infrastructure for cell-based...